Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

Promising cancer treatments were found, but the manufacturer closed.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Gefitinib can cause rare scarring hair loss.

Afatinib often causes skin problems that need proactive management.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Gefitinib can cause hair and eyebrow darkening.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.